Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model

Curtis A. Lachowiez

Oregon Health & Science University, Portland, Oregon, United States

Joshua F. Zeidner

1Division of Hematology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC

Jad Othman

3The University of Sydney, Sydney, Australia

Andy Kaempf

1Oregon Health & Science University, Division of Hematologic Malignancies, Knight Cancer Institute, Portland, United States

Seongseok Yun

Moffitt Cancer Cancer and Research Institute, Tampa, Florida, United States

Maël Heiblig

9Department of Hematology, Centre Hospitalier Universitaire de Lyon, Lyon, France

Michael Heuser

Rabia Shahswar

4Hannover Medical School, Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany

Rafael Madero Marroquin

Joseph M. Cannova

Andrius Zucenka

1Vilnius University, Faculty of Medicine and Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania

Jennifer Marvin-Peek

2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Jayastu Senapati

The University of Texas MD Anderson Cancer Center

Yasmin Abaza

19Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Division of Hematology and Oncology, Leukemia Program, Chicago, United States

Alok Swaroop

Irene Zacheo

1919. IRST IRCCS, Meldola, Forlì-Cesena, forlì cesena, Italy

Federica Monaco

11Department of Hematology, Ospedali Infermi, AUSLROMAGNA, Rimini, Italy

Amine Belhabri

19Service d’Hématologie, Centre Léon-Bérard, Lyon, France

Urbain Tauveron-Jalenques

3Centre Hospitalier Universitaire Clermont-Ferrand, Service d'hématologie et thérapie cellulaire, Clermont-Ferrand, France

Emmanuelle Tavernier

Martin Carré

Gaspar Aspas Requena

8CHU Clermont-Ferrand, Department of Hematology, Clermont-Ferrand, France

Rachel J. Cook

Elie Traer

Oregon Health & Science University, Portland, Oregon, United States

Jennifer N. Saultz

Jenny O'Nions

13Department of Hematology, University College London Hospital NHS Foundation Trust, London, United Kingdom

Faisal Basheer

13Addenbrooke's Hospital, Department of Haematology, Cambridge, United Kingdom

John Laurie

14University Hospitals Sussex NHS Foundation Trust, Worthing, United Kingdom

Shivani Handa

The Ohio State University, Columbus, Ohio, United States

Eytan M. Stein

Leukemia Service Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA

Maria R. Baer

10University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD

Rebecca Olin

1University of California, San Francisco, Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, San Francisco, United States

William Blum

Emory University, Atlanta, Georgia, United States

Gary Schiller

7David Geffen School of Medicine at UCLA, Los Angeles, United States

Tara Lin

20University of Kansas Cancer Center, Westwood, United States

Emily Curran

University of Cincinnati College of Medicine, Cincinnati, Ohio, United States

Ashley Yocum

14Blood Cancer United, Washington, United States

Ellen Madarang

2University of Miami Miller School of Medicine, Leukemia Service, Department of Medicine, Miami, United States

Naval Daver

1The University of Texas MD Anderson Cancer Center, Houston, TX

Tapan M. Kadia

Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA

Giovanni Marconi

31Hematology Unit, Ospedale S. Maria delle Croci, University of Bologna, Ravenna, Italy

Yazan Madanat

Richard Dillon

5King's College London, London, United Kingdom

Courtney D. DiNardo

Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA

Ronan Swords

OHSU Knight Cancer Institute Center for Hematologic Malignancies, Portland, Oregon, United States

Juan E. Arango Ossa

Justin Watts

2Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Medicine, Miami, United States

Sanam Loghavi

Daniel A. Pollyea

4Division of Hematology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO

Elsa Bernard

2Institut Gustave Roussy, Computational Clinical Oncology Lab, UMR 981, Villejuif, France